Optiscan software breakthrough will bring pathologists to the bedside
ASX-listed medical technology innovator Optiscan Imaging has just fired a major shot across the bow of the global diagnostics industry with the launch of its game-changing cloud-based telepathology platform prototype.
With healthcare systems under pressure globally, and regional hospitals and patients often left out of access to specialist services and innovations, Optiscan’s new telepathology platform appears to offer a timely solution.
On the back of its prototype milestone, the company isn’t just imaging the future of pathology - it’s live-streaming it.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)